Showing results (91-100 of 189) with videos related to

Sort By:
Pageof 19
European Journal of Immunology|January 27, 2010
Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ TregRahul Kushwah, Jing Wu, Jordan R Oliver, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2005
Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterpartsJanet I Malowany, Sarah McCormick, Michael Santosuosso, et al.
Journal of Translational Medicine|October 31, 2021
Gene therapy for cystic fibrosis: new tools for precision medicineJin-A Lee, Alex Cho, Elena N Huang, et al.
RNA Biology|April 20, 2010
Alternative polyadenylation of MeCP2: Influence of cis-acting elements and trans-acting factorsCatherine M Newnham, Tyra Hall-Pogar, Songchun Liang, et al.
Nucleic Acids Research|June 10, 2005
A complementation method for functional analysis of mammalian genesJuana Maria Gonzalez-Santos, Huibi Cao, Anan Wang, et al.
The Journal of Clinical Investigation|November 5, 2019
Endogenous T cells prevent tumor immune escape following adoptive T cell therapyScott R Walsh, Boris Simovic, Lan Chen, et al.
The Journal of Clinical Investigation|November 14, 2018
Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicityScott R Walsh, Donald Bastin, Lan Chen, et al.
Innate Immunity|March 10, 2015
Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunityKhalil Karimi, Yalda Karimi, Jeffrey Chan, et al.
The Journal of Clinical Investigation|February 3, 2004
TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infectionAnna Zganiacz, Michael Santosuosso, Jun Wang, et al.
Pageof 19